Aug 12, 2020
Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in China
Aug 11, 2020
Children's Minnesota physician appointed inaugural holder of Pine Tree Apple Tennis Classic Endowed Chair in Cancer and Blood Disorders Research
Aug 11, 2020
As COVID-19 Cases Spike, American Lung Association and Queen Latifah Partner to Raise Funds for Communities Hit Hardest
Jun 22, 2020
LUNGevity and EGFR Resisters Collaborate on Lung Cancer Research Awards
Jun 22, 2020
Lung Cancer Research Foundation Names Dr. Trudy Oliver to its Scientific Advisory Board
Jun 18, 2020
Association Of Community Cancer Centers Releases Preliminary Findings From Survey On Advanced Non-Small Cell Lung Cancer Care
Jun 18, 2020
How to Stay Safe this Summer as COVID-19 Restrictions Lift
Jun 16, 2020
Nation Turns Turquoise as Symbol of Hope for those Facing Lung Cancer during Pandemic
Jun 15, 2020
Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca(TM) (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer
Jun 03, 2020
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis
May 30, 2020
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
May 29, 2020
Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
May 29, 2020
Blueprint Medicines Announces Data Presentations at ASCO20 Highlighting Deep, Durable Clinical Activity and Well-Tolerated Safety Profile of Pralsetinib Across Broad Range of RET Fusion-Positive Tumors
May 27, 2020
Xylyx Bio releases advanced disease model system to improve cancer drug discovery
May 19, 2020
Small Cell Lung Cancer (SCLC) Market Insights, Epidemiology and Forecast to 2030
May 18, 2020
Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring Exon 20 Insertion Mutations
May 13, 2020
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020
Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program
May 13, 2020
GO2 Foundation for Lung Cancer Names Jennifer C. King, Ph.D. as Chief Scientific Officer
May 12, 2020
Non-Small Cell Lung Cancer (NSCLC) Market Forecasts to 2030: A Comprehensive Insight